Table 4

Top nine funders ranked by total amount of funding given to support the research and development of the ChAdOx technology and Oxford–AstraZeneca vaccine, based on Freedom Of Information requests to the University of Oxford

Rank based on total amountFunderChAdOx technology (to SG and AH only), £ (%)Oxford–AstraZeneca vaccine, £ (%)Total, £ (%)
1Department of Health and Social Care0 (0.0)31 179 621 (89.3)31 179 621 (29.9)
2European Commission23 545 255 (34.0)0 (0.0)23 545 255 (22.6)
3Wellcome Trust14 144 606 (20.4)1 217 835 (3.5)15 362 440 (14.7)
4Coalition for Epidemic Preparedness and Innovations12 098 260 (17.5)272 286 (0.8)12 370 546 (11.9)
5Medical Research Council3 080 837 (4.4)2 174 848 (6.2)5 255 685 (5.0)
6Foundation for National Institute of Health (US)5 729 292 (8.3)0 (0.0)5 729 292 (5.5)
7Innovate UK2 403 678 (3.5)0 (0.0)2 403 678 (2.3)
8European & Developing Countries Clinical Trials Partnership2 209 747 (3.2)0 (0)2 209 747 (2.1)
9Bill and Melinda Gates Foundation1 595 006 (2.3)0 (0.0)1 595 006 (1.5)
10–20Other£4 506 697 (6.5%)68 106 (0.2)4 574 803 (4.4)
Total69 313 37934 912 696104 226 076
  • Funders which contributed >£1 000 000 are shown.

  • AH, Professor Adrian Hill; ChAdOx, chimpanzee adenovirus-vectored vaccine; SG, Sarah Gilbert.